The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Nov. 14, 2019
Applicant:

Helmholtz Zentrum München—deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh), Neuherberg, DE;

Inventors:

Heiko Lickert, Munich, DE;

Adriana Migliorini, Munich, DE;

Moritz Gegg, Munich, DE;

Erik Bader, Munich, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C12Q 1/6881 (2018.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); A61K 38/17 (2006.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
G01N 33/507 (2013.01); A61K 38/1709 (2013.01); C12N 5/0676 (2013.01); C12Q 1/6881 (2013.01); G01N 33/56966 (2013.01); G01N 33/6893 (2013.01); C12N 2501/00 (2013.01); C12N 2501/415 (2013.01); C12N 2501/727 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/042 (2013.01);
Abstract

The present invention relates to the use of the biomarker Flattop (Fltp) for distinguishing mature β cells from immature progenitor β cells. The present invention further relates to a method for distinguishing a mature β cell from an immature progenitor β cell, the method comprising: determining the presence or absence of the biomarker Flattop (Fltp) in a β cell; wherein the presence of Fltp in the cell indicates that the cell is a mature β cell and wherein the absence of Fltp in the cell indicates that the cell is an immature progenitor β cell. Furthermore, the present invention relates to a method of identifying a compound suitable for differentiating immature progenitor β cells into mature β cells as well as to a method of identifying a compound suitable for preventing the de-differentiating of mature β cells. The present invention additionally relates to a method of differentiating immature progenitor β cells into mature β cells as well as to a method of preventing de-differentiating of mature β cells. In addition, the present invention also relates to a kit for distinguishing mature β cells from immature progenitor β cells and to a pharmaceutical composition for use in treating or preventing diabetes.


Find Patent Forward Citations

Loading…